Forward genetic screen in C. elegans maps genes that modulate alpha-synuclein neurodegeneration via mitochondrial UPR
A bioRxiv preprint reports a forward genetic screen identifying modulators of alpha-synuclein-induced dopaminergic neuron loss through the mitochondrial unfolded protein response pathway in C. elegans.
Researchers at Cold Spring Harbor Laboratory have posted a preprint on bioRxiv describing a forward genetic screen in Caenorhabditis elegans designed to identify genes that alter neurodegeneration caused by overexpression of alpha-synuclein (α-syn), the protein implicated in Parkinson's disease and related synucleinopathies.
The study builds on an established C. elegans model in which α-syn overexpression chronically activates the mitochondrial unfolded protein response (UPRmt) and causes loss of dopaminergic neurons. The authors introduced a loss-of-function allele in atfs-1 — the principal transcriptional regulator of UPRmt — into α-syn-expressing nematodes and observed significant neuroprotection, suggesting that compensatory mechanisms can offset α-syn-induced neuronal loss when canonical UPRmt signalling is disrupted.
Using an F3 forward genetic screen in atfs-1 loss-of-function mutants, the team sought to identify additional genetic modifiers of this neuroprotective effect. The approach leverages the speed and tractability of C. elegans genetics to uncover potential molecular targets relevant to synuclein-driven neurodegeneration. Because this work is a preprint and has not yet undergone peer review, findings should be interpreted with appropriate caution pending independent validation.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
Researchers have published early-stage laboratory findings — currently a preprint, meaning they have not yet been independently checked through peer review — describing experiments in a tiny roundworm called C. elegans. The worm was used as a model to study alpha-synuclein, a protein that builds up abnormally in the brains of people with Parkinson's disease.
The study looked at how a cellular stress response called the mitochondrial unfolded protein response — a system cells use when proteins are not folding correctly — affects the survival of nerve cells in the worm. By switching off a key gene in this pathway, the researchers found they could protect dopamine-producing nerve cells from damage caused by alpha-synuclein. They then screened for other genes that could produce similar protective effects.
This is basic laboratory research in a model organism; it does not directly translate to treatments for people with Parkinson's disease. Much more research would be needed before any implications for human health could be considered.
This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary sourcePreprint bioRxiv (Cold Spring Harbor Laboratory) · 2026-06-15A Forward Genetic Screen in Caenorhabditis elegans for Genes that Modulate α-synuclein-Induced Neurodegeneration through the Mitochondrial UPR